1/14
05:26 pm
opk
Is OPKO Health (OPK) Pricing Reflect Its DCF Upside Despite Weak Long Term Returns [Yahoo! Finance]
Low
Report
Is OPKO Health (OPK) Pricing Reflect Its DCF Upside Despite Weak Long Term Returns [Yahoo! Finance]
1/13
11:21 am
opk
7MM Hyperparathyroidism, Hyperphosphatemia, and Hyperkalemia in Chronic Kidney Disease Market Opportunity Assessment and Forecasts 2024-2034 [Yahoo! Finance]
Low
Report
7MM Hyperparathyroidism, Hyperphosphatemia, and Hyperkalemia in Chronic Kidney Disease Market Opportunity Assessment and Forecasts 2024-2034 [Yahoo! Finance]
1/12
11:08 am
opk
AI genome sequencing could transform rare disease diagnosis: GeneDx CEO [FOX Business Network]
Low
Report
AI genome sequencing could transform rare disease diagnosis: GeneDx CEO [FOX Business Network]
1/7
03:36 pm
opk
Is GeneDx Holdings (WGS) Pricing Look Attractive After Mixed Long Term Share Performance [Yahoo! Finance]
Low
Report
Is GeneDx Holdings (WGS) Pricing Look Attractive After Mixed Long Term Share Performance [Yahoo! Finance]
1/7
09:17 am
opk
GeneDx Announces GenomeDx Prenatal™, Expanding Industry-Leading Genomic Diagnosis Into Prenatal Care [Yahoo! Finance]
Medium
Report
GeneDx Announces GenomeDx Prenatal™, Expanding Industry-Leading Genomic Diagnosis Into Prenatal Care [Yahoo! Finance]
1/6
04:11 pm
opk
OPKO Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference
Medium
Report
OPKO Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference
1/6
08:41 am
opk
OPKO Health Bets on RAYALDEE and Pipeline Progress for 2026 Growth [Yahoo! Finance]
Medium
Report
OPKO Health Bets on RAYALDEE and Pipeline Progress for 2026 Growth [Yahoo! Finance]
1/5
09:06 am
opk
GeneDx Leads Rare Disease Genomics with Unmatched Research and Clinical Impact in 2025 [Yahoo! Finance]
Low
Report
GeneDx Leads Rare Disease Genomics with Unmatched Research and Clinical Impact in 2025 [Yahoo! Finance]
12/30
09:37 am
opk
GeneDx to Present at the J.P. Morgan 2026 Healthcare Conference [Yahoo! Finance]
Low
Report
GeneDx to Present at the J.P. Morgan 2026 Healthcare Conference [Yahoo! Finance]
12/21
01:08 am
opk
Low
Report
12/15
08:57 am
opk
JAMA (Journal of the American Medical Association) Recognizes GUARDIAN Newborn Genomic Screening Study Among Its Research of the Year [Yahoo! Finance]
Low
Report
JAMA (Journal of the American Medical Association) Recognizes GUARDIAN Newborn Genomic Screening Study Among Its Research of the Year [Yahoo! Finance]
11/21
02:33 am
opk
The Bull Case For OPKO Health (OPK) Could Change Following CEO Frost's Major Share Purchase Amid Downgrade [Yahoo! Finance]
Low
Report
The Bull Case For OPKO Health (OPK) Could Change Following CEO Frost's Major Share Purchase Amid Downgrade [Yahoo! Finance]
11/20
08:07 am
opk
OPKO Health (NASDAQ:OPK) is now covered by analysts at JPMorgan Chase & Co.. They set a "neutral" rating on the stock.
Medium
Report
OPKO Health (NASDAQ:OPK) is now covered by analysts at JPMorgan Chase & Co.. They set a "neutral" rating on the stock.
11/19
04:05 pm
opk
OPKO Health to Participate in the Piper Sandler 37th Annual Healthcare Conference
Low
Report
OPKO Health to Participate in the Piper Sandler 37th Annual Healthcare Conference
11/15
11:51 pm
opk
Guggenheim Reaffirmed Buy on GeneDx at October End, Lifted Price Target to $170 After Q3 Beat [Yahoo! Finance]
Low
Report
Guggenheim Reaffirmed Buy on GeneDx at October End, Lifted Price Target to $170 After Q3 Beat [Yahoo! Finance]
11/6
08:18 am
opk
GeneDx to Showcase Advancements in Gene-Disease Discovery, Long-Read Sequencing and More at National Society of Genetic Counselors (NSGC) 2025 Annual Meeting [Yahoo! Finance]
Low
Report
GeneDx to Showcase Advancements in Gene-Disease Discovery, Long-Read Sequencing and More at National Society of Genetic Counselors (NSGC) 2025 Annual Meeting [Yahoo! Finance]
10/30
11:45 pm
opk
Opko Health Inc.'s (OPK) ModeX Therapeutics Announces License and Collaboration Agreement With Regeneron Pharmaceuticals [Yahoo! Finance]
Low
Report
Opko Health Inc.'s (OPK) ModeX Therapeutics Announces License and Collaboration Agreement With Regeneron Pharmaceuticals [Yahoo! Finance]
10/30
07:01 pm
opk
OPKO Health (NASDAQ:OPK) was given a new $1.60 price target on by analysts at Jefferies Financial Group Inc..
Medium
Report
OPKO Health (NASDAQ:OPK) was given a new $1.60 price target on by analysts at Jefferies Financial Group Inc..
10/30
08:09 am
opk
OPKO Health (NASDAQ:OPK) had its "outperform" rating reaffirmed by analysts at Barrington Research. They now have a $2.25 price target on the stock.
Low
Report
OPKO Health (NASDAQ:OPK) had its "outperform" rating reaffirmed by analysts at Barrington Research. They now have a $2.25 price target on the stock.
10/29
04:05 pm
opk
OPKO Health Reports Third Quarter 2025 Business Highlights and Financial Results
Low
Report
OPKO Health Reports Third Quarter 2025 Business Highlights and Financial Results
10/29
08:00 am
opk
OPKO Health’s ModeX Therapeutics Enters into Research Collaboration with Regeneron to Develop Multispecific Antibodies for Select Therapeutic Indications
Medium
Report
OPKO Health’s ModeX Therapeutics Enters into Research Collaboration with Regeneron to Develop Multispecific Antibodies for Select Therapeutic Indications
10/28
08:00 am
opk
OPKO Health’s ModeX Therapeutics Begins Clinical Trial of MDX2004 for the Treatment of Advanced Cancers
Low
Report
OPKO Health’s ModeX Therapeutics Begins Clinical Trial of MDX2004 for the Treatment of Advanced Cancers
10/27
01:00 pm
opk
Greenberg Traurig Selected as Winner at 2025 Beacon Awards in Professional Services Category
Low
Report
Greenberg Traurig Selected as Winner at 2025 Beacon Awards in Professional Services Category
10/22
04:05 pm
opk
OPKO Health to Report Third Quarter 2025 Financial Results on October 29
Low
Report
OPKO Health to Report Third Quarter 2025 Financial Results on October 29